Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study

被引:0
|
作者
Weingarten, Toby N. [1 ]
Taccolini, Ashley M. [1 ]
Ahle, Samuel T. [1 ]
Dietz, Kelsey R. [1 ]
Dowd, Shaun S. [1 ]
Frank, Igor [2 ]
Boorjian, Stephen A. [2 ]
Thapa, Prabin [3 ]
Hanson, Andrew C. [3 ]
Schroeder, Darrell R. [3 ]
Sprung, Juraj [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Anesthesiol, 200 First St SW, Rochester, MN USA
[2] Mayo Clin, Coll Med, Dept Urol, 200 First St SW, Rochester, MN USA
[3] Mayo Clin, Coll Med, Hlth Sci Res & Biomed Stat & Informat, 200 First St SW, Rochester, MN USA
关键词
ALLOGENEIC BLOOD-TRANSFUSION; KILLER-CELL CYTOTOXICITY; COLORECTAL-CANCER; EPIDURAL-ANESTHESIA; POSTOPERATIVE INFECTION; NEURAXIAL ANESTHESIA; GENERAL-ANESTHESIA; TUMOR RECURRENCE; CONTROLLED-TRIAL; FREE SURVIVAL;
D O I
10.1007/s12630-016-0599-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The immune system plays an important role in tumour progression. Systemic opioids are immunosuppressive; thus, theoretically they may promote tumour spread. Our primary aim was to test the hypothesis that general anesthesia (GA) with spinal analgesia (SA) in patients with bladder cancer undergoing radical cystectomy (RC) will both reduce systemic opioid use and improve oncological outcomes. Since blood transfusions also induce immunosuppression, a secondary aim was to evaluate the effect of perioperative transfusions on oncological outcomes. One hundred ninety-five patients who underwent RC with GA+SA from 1998-2007 were matched 1:1 to controls who underwent surgery with GA only using propensity scoring and tumour characteristics known to be highly associated with oncological outcomes. Medical records were reviewed for use of opioids and transfusions. Outcomes were tumour recurrence, cancer-specific mortality, and all-cause mortality. Survival was estimated using the Kaplan-Meier method, and associations of anesthetic technique and transfusions with outcomes were analyzed using stratified multivariable proportional hazard regression. Systemic opioid use was reduced with GA+SA relative to GA (P < 0.001). There was no difference between groups with respect to all-cause mortality (hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.77 to 1.53; P = 0.636), bladder cancer mortality (HR, 1.03; 95% CI, 0.66 to 1.61; P = 0.893), or cancer recurrence (HR, 1.32; 95% CI, 0.86 to 2.02; P = 0.205). Nevertheless, patients who were perioperatively transfused had an increased all-cause mortality (HR, 2.21; 95% CI, 1.11 to 4.40; P = 0.025), and cancer-specific mortality (HR, 2.61; 95% CI, 1.05 to 6.48; P = 0.039). In patients undergoing RC, the opioid-sparing effect with SA was not associated with improved oncological outcomes, while blood transfusion was associated with increased mortality.
引用
收藏
页码:584 / 595
页数:12
相关论文
共 50 条
  • [31] Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan
    Kanno, Toru
    Inoue, Takahiro
    Kawakita, Mutsushi
    Ito, Katsuhiro
    Okumura, Kazuhiro
    Yamada, Hitoshi
    Kubota, Masashi
    Fujii, Masato
    Shimizu, Yosuke
    Yatsuda, Junji
    Kobori, Go
    Moroi, Seiji
    Shichiri, Yasumasa
    Akao, Toshiya
    Sawada, Atsuro
    Saito, Ryoichi
    Kobayashi, Takashi
    Ogawa, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (06) : 559 - 565
  • [32] Outcomes following radical cystectomy for patients diagnosed with bladder cancer in Queensland
    Coughlin, Geoffrey
    Youl, Philippa
    Philpot, Shoni
    Theile, David E.
    Moore, Julie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 137 - 137
  • [33] Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes
    Yoo, Sang Hyun
    Kim, Hwanik
    Kwak, Cheol
    Kim, Hyeon Hoe
    Jung, Jae Hyun
    Ku, Ja Hyeon
    UROLOGIA INTERNATIONALIS, 2019, 103 (03) : 291 - 296
  • [34] Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer
    Kaag, Matthew G.
    Raman, Jay D.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S732 - S734
  • [35] Radical cystectomy and perioperative chemotherapy in octogenarians with bladder cancer
    Savin, Ziv
    Herzberg, Haim
    Schreter, Eran
    Ben-David, Reuben
    Bar-Yosef, Yuval
    Sofer, Mario
    Beri, Avi
    Yossepowitch, Ofer
    Mano, Roy
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (09): : E465 - E470
  • [36] Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
    Burden, Sorrel
    Billson, Hazel A.
    Lal, Simon
    Owen, Kellie A.
    Muneer, Asif
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
  • [37] Outcomes Following Radical Cystectomy for Nested Variant of Urothelial Carcinoma: A Matched Cohort Analysis
    Linder, Brian J.
    Frank, Igor
    Cheville, John C.
    Thompson, R. Houston
    Thapa, Prabin
    Tarrell, Robert F.
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2013, 189 (05): : 1670 - 1675
  • [38] ONCOLOGICAL TRIFECTA AND PENTAFECTA CRITERIA IN A CONTEMPORARY COHORT OF BLADDER CANCER PATIENTS AFTER RADICAL CYSTECTOMY
    Henske, Julian
    von Landenberg, Nicolas
    Berg, Sebastian
    Schmidt, Jana
    Brock, Marko
    von Bodman, Christian
    Palisaar, Jueri
    Roghmann, Florian
    Noldus, Joachim
    JOURNAL OF UROLOGY, 2016, 195 (04): : E536 - E537
  • [39] Perioperative, oncological, and survival outcomes of robotic radical cystectomy with urinary diversion in females: A single-center retrospective observational study
    Agarwal, Varun
    Thyavihally, B. Yuvaraja
    Waigankar, Santosh Subash
    Dev, Preetham
    Pednekar, Abhinav
    Roy, Diptiman
    Athikari, Nevitha
    Hastak, Meenal
    Badlani, Naresh
    Pokharkar, D. Harshwardhan
    Ayyalasomayajula, Nagaraja Sekar
    Khandekar, Archan
    Asari, Ashish
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (01) : 27 - 32
  • [40] Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study
    Miki, Jun
    Fukuokaya, Wataru
    Taoka, Rikiya
    Saito, Ryoichi
    Matsui, Yoshiyuki
    Hatakeyama, Shingo
    Kawahara, Takashi
    Matsuda, Ayumu
    Kawai, Taketo
    Kato, Minoru
    Sazuka, Tomokazu
    Sano, Takeshi
    Urabe, Fumihiko
    Kashima, Soki
    Naito, Hirohito
    Murakami, Yoji
    Nishiyama, Naotaka
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (09) : 1009 - 1016